You are here

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review with meta analysis
Drug-eluting stents and drug-eluting balloons are the best strategies to treat coronary in-stent restenosis

http://dx.doi.org/10.1136/ebmed-2015-110372

Statistics from Altmetric.com

    Footnotes

    • Competing interests RM has received consultant and speaker honoraria (modest level) from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Daiichi Sankyo, Abbott Vascular, AstraZeneca, Boston Scientific, and Johnson & Johnson.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/